
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 455
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 455
Showing 1-25 of 455 citing articles:
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 737
Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 737
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 123
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 123
Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 118
Qingfang Li, Zhihui Li, Ting Luo, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 118
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Targeting Breast Cancer: An Overlook on Current Strategies
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 45
Domenico Iacopetta, Jessica Ceramella, Noemi Baldino, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3643-3643
Open Access | Times Cited: 45
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
Diana-Theodora Morgos, Constantin Ștefani, Daniela Miricescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1848-1848
Open Access | Times Cited: 44
Diana-Theodora Morgos, Constantin Ștefani, Daniela Miricescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1848-1848
Open Access | Times Cited: 44
Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 25
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 25
The Potential Health Benefits of Gallic Acid: Therapeutic and Food Applications
Milad Hadidi, Rafael Liñán-Atero, Mohammad Tarahi, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 1001-1001
Open Access | Times Cited: 24
Milad Hadidi, Rafael Liñán-Atero, Mohammad Tarahi, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 1001-1001
Open Access | Times Cited: 24
PI3K/AKT signaling pathway: Molecular mechanisms and therapeutic potential in depression
Ningning Guo, Xin Wang, Muran Xu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107300-107300
Open Access | Times Cited: 23
Ningning Guo, Xin Wang, Muran Xu, et al.
Pharmacological Research (2024) Vol. 206, pp. 107300-107300
Open Access | Times Cited: 23
Exosomes: compositions, biogenesis, and mechanisms in diabetic wound healing
Yichuan Li, Zhanyong Zhu, Sicheng Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
Yichuan Li, Zhanyong Zhu, Sicheng Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 20
MicroRNA-21's role in PTEN suppression and PI3K/AKT activation: Implications for cancer biology
Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155091-155091
Closed Access | Times Cited: 19
Himmat Singh Chawra, Mohit Agarwal, Anurag Mishra, et al.
Pathology - Research and Practice (2024) Vol. 254, pp. 155091-155091
Closed Access | Times Cited: 19
Promotion of ROS-mediated apoptosis, G2/M arrest, and autophagy by naringenin in non-small cell lung cancer
Tsung‐Ming Chang, Miao‐Ching Chi, Yao‐Chang Chiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 1093-1109
Open Access | Times Cited: 19
Tsung‐Ming Chang, Miao‐Ching Chi, Yao‐Chang Chiang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 3, pp. 1093-1109
Open Access | Times Cited: 19
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 19
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 19
Targeting PI3K/Akt in Cerebral Ischemia Reperfusion Injury Alleviation: From Signaling Networks to Targeted Therapy
Ting Zheng, Taotao Jiang, Hongxiang Ma, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7930-7949
Closed Access | Times Cited: 17
Ting Zheng, Taotao Jiang, Hongxiang Ma, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 10, pp. 7930-7949
Closed Access | Times Cited: 17
Helicobacter pylori and gastric cancer: mechanisms and new perspectives
Yantao Duan, Yonghu Xu, Yi Dou, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Yantao Duan, Yonghu Xu, Yi Dou, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 6
Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
The molecular code of kidney cancer: A path of discovery for gene mutation and precision therapy
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 2
Deqian Xie, Guandu Li, Zhonghua Zheng, et al.
Molecular Aspects of Medicine (2025) Vol. 101, pp. 101335-101335
Open Access | Times Cited: 2
Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
Shufen Liu, Tingting Liu, Jingwen Li, et al.
Neuroscience Bulletin (2025)
Closed Access | Times Cited: 2
Insight into the Role of the PI3K/Akt Pathway in Ischemic Injury and Post-Infarct Left Ventricular Remodeling in Normal and Diabetic Heart
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1553-1553
Open Access | Times Cited: 64
Bartosz Walkowski, Marcin Kleibert, Miłosz Majka, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1553-1553
Open Access | Times Cited: 64
Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114971-114971
Closed Access | Times Cited: 43
Maria Antonietta Occhiuzzi, Gernando Lico, Giuseppina Ioele, et al.
European Journal of Medicinal Chemistry (2022) Vol. 246, pp. 114971-114971
Closed Access | Times Cited: 43
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers
Lin Li, Qing Wu, Feifei Lu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 40
Lin Li, Qing Wu, Feifei Lu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 40
Anticancer Potential of the Plant‐Derived Saponin Gracillin: A Comprehensive Review of Mechanistic Approaches
Md. Shimul Bhuia, Raihan Chowdhury, Fatema Akter Sonia, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 34
Md. Shimul Bhuia, Raihan Chowdhury, Fatema Akter Sonia, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 9
Closed Access | Times Cited: 34
On a sugar high: Role of O-GlcNAcylation in cancer
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 33
Giang Lê Minh, Emily M. Esquea, Riley G. Young, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 11, pp. 105344-105344
Open Access | Times Cited: 33
Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 32
Ziyu Ji, Jianlin Shen, Yujian Lan, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 32